Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

19961,164 citationsJournal Articlebronze Open Access

Authors

Lucien Abenhaim · McGill University

Yola Moride · McGill University

François Brenot · Hôpital Antoine-Béclère

Stuart Rich · University of Illinois Chicago

Jacques Bénichou

Xavier Kurz · Centre Hospitalier Universitaire de Liège

Tim Higenbottam · University of Sheffield

Abstract

The use of anorexic drugs was associated with the development of primary pulmonary hypertension. Active surveillance for this disease should be considered, particularly since their use is expected to increase in the near future.

Topics & Keywords

Pulmonary Hypertension Research and Treatments Cardiovascular, Neuropeptides, and Oxidative Stress Research Liver Disease and Transplantation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 335, Issue 9, pp. 609-616

DOI: 10.1056/nejm199608293350901

Field-Weighted Citation Impact: 79.77